शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
YASHONSEYasho Industries Limited· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 12 Feb, 2026 · 15:54 IST

Yasho Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

Revenue growth above 20%Profit growth above 25%Results View source PDFExplain this filing

YASHO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹1372.00
prior close
₹1387.10
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.5%+1.7% vs market
Specialty Chemicals peers, median of 86sector-1.6%+1.9% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.9 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.9
10m
-2.4
15m
-2.4
30m
-2.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2-1.5+1.7-1.6+1.9
Next day
+8.6-2.2+10.8-3.0+11.6
2d
+9.3-1.2+10.5-2.5+11.8
3d
+9.2-0.9+10.1-1.7+10.9
4d
+8.6-2.3+10.9-3.1+11.7
5d
+8.6-2.5+11.1-3.0+11.6
1w
+5.5-3.6+9.1-3.6+9.2
15d
+6.0-10.4+16.4-10.4+16.3
1m
-4.9-11.3+6.4-11.3+6.4
2m
+10.8-3.6+14.3-5.9+16.7
3m
+17.6+3.9+13.7+0.8+16.7
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Yasho Industries reported strong Q3 FY26 (ended Dec 31, 2025) results with standalone revenue from operations rising about 31% year-on-year to Rs 19,814 lakhs (from Rs 15,121 lakhs). Consolidated revenue grew around 35% to Rs 20,183 lakhs. The company swung back to profit with standalone PAT of Rs 349.51 lakhs versus a loss of Rs 94.32 lakhs in Q3 FY25, and consolidated PAT of Rs 449.60 lakhs versus a loss of Rs 82.22 lakhs. For the nine months ended December 2025, standalone PAT jumped to Rs 1,199.40 lakhs (from Rs 174.66 lakhs) and consolidated PAT to Rs 1,299.80 lakhs (from Rs 107.49 lakhs). Statutory auditors Gokhale & Sathe issued an unmodified review report. The Board also approved appointing Aneja Assurance as the new internal auditor from April 1, 2026, replacing Proteus Advisors whose tenure is ending.

Likely market impact

Strong revenue growth and a sharp swing back to profitability signal improving operating performance and likely positive sentiment for the stock. Investors may view the results as evidence of recovery in the chemicals business, while the planned internal auditor change is routine and not a red flag.